Can-Fite BioPharma Ltd.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $5.5M | $4.8M | $4.3M | $3.0M | $4.4M | $8.3M | $2.7M | $3.6M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $9.4M | $9.0M | $9.9M | $9.2M | $20.1M | $9.4M | $7.1M | $7.9M |
| Property, Plant & Equipment | $5.0K | $27.0K | $29.0K | $42.0K | $47.0K | $50.0K | $36.0K | — |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $9.5M | $9.1M | $10.0M | $9.3M | $20.3M | $9.5M | $8.2M | $8.0M |
| Liabilities | ||||||||
| Accounts Payable | $1.2M | $618.0K | $427.0K | $896.0K | $954.0K | $561.0K | $2.2M | — |
| Total Current Liabilities | $2.7M | $2.1M | $2.0M | $2.5M | $2.7M | $1.3M | $3.3M | $3.1M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $3.9M | $3.7M | $3.7M | $4.8M | $5.9M | $3.4M | $5.7M | $4.9M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-176.2M | $-166.4M | $-158.5M | $-150.8M | $-140.7M | $-125.5M | $-110.3M | $-100.6M |
| Total Stockholders' Equity | $5.6M | $5.4M | $6.2M | $4.5M | $14.4M | $6.1M | $2.4M | $3.0M |